Richard Malamut, MD
Chief Medical Officer
Rick Malamut has over 25 years of industry, clinical and academic experience including strategic and operational leadership of clinical development, medical affairs and R&D operations. In his role at Braeburn, he leads clinical development, R&D, medical affairs, pharmacovigilance and biostatistics. Prior to Braeburn, Rick was Chief Medical Officer at Avanir Pharmaceuticals where he oversaw Clinical Development, Non-Clinical Development, Pharmacovigilance, R&D Operations, Biostatistics, Regulatory Affairs, and Medical Affairs. Previously, he was the Senior Vice President of Global Clinical Development at Teva Pharmaceutical Industries Ltd. His experience also includes roles of increasing responsibility focusing on early clinical development and translational medicine at Bristol-Myers Squibb and AstraZeneca. Rick earned his medical degree from Hahnemann University and has completed both a residency in Neurology and a fellowship in Neuromuscular disease. He worked as a board-certified Academic/Clinical neurologist for 17 years and has more than 50 publications.